Article

Refractec files PMA for presbyopia procedure

Irvine, CA-Refractec Inc. has filed its pre-market approval application with the FDA for a conductive keratoplasty (CK) procedure designed for patients with presbyopia.

Related Videos
Dr. Analisa Arosemena discusses glaucoma at EyeCon 2024
Dr. Amir Ghanipour discusses light adjustable lenses for cataracts at EyeCon 2024
Related Content
Site Logo
October 8th 2024

Eyes on the Prize: Winning Strategies to Help Your Practice Thrive

Ehsan Sadri, MD, and Colin Green, PhD: How a noninvasive eye drop therapy could transform keratoconus care
September 23rd 2024

Innovation Series: What a noninvasive eye drop approach may mean for the future of keratoconus

New study identifies common mechanism behind age-related macular degeneration and related macular dystrophies
October 8th 2024

New study identifies common mechanism behind age-related macular degeneration and related macular dystrophies

Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics
August 30th 2024

Latest advances in X-linked retinitis pigmentosa: Optimizing diagnosis and developments in gene therapy

ASU researchers tap AI to help people see more clearly
October 7th 2024

ASU researchers tap AI to help people see more clearly

Brain-to-eye β-amyloid transport and Alzheimer's Disease retinopathy
October 7th 2024

Brain-to-eye β-amyloid transport and Alzheimer's Disease retinopathy

© 2024 MJH Life Sciences

All rights reserved.